Harbin Pharmaceutical Group Co Ltd (600664.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE0000009T3
Harbin Pharmaceutical Group Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 16.18 bn CNY | 15.96 bn CNY |
| Gross profit | 4.52 bn CNY | 4.15 bn CNY |
| Operating income | 890.20 m CNY | 730.51 m CNY |
| EBIT | 849.71 m CNY | 615.29 m CNY |
| Net income | 628.85 m CNY | 361.60 m CNY |
| Diluted EPS – continuing operations | 0.25 CNY | 0.14 CNY |
Full history since 1993, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Harbin Pharmaceutical Group Co Ltd
Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, antiviral and anti-infective, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, human erythropoietin injections, iron and vitamin B12 oral solutions, calcium, iron, and zinc oral solutions, ceftriaxone sodium injections, Qufenggutong gel ointment, GNC Vitapak nutritional pack, lacidipine tablets, GNC fish oil capsules, coenzyme Q10 and panthenol soft capsules, GNC children's liquid calcium magnesium zinc, penicillin sodium, acetaminophen and chlorpheniramine maleate granules, glucosamine chondroitin calcium tablets, ceftriaxone sodium for injection, GNC milk thistle extract tablets and capsules, and compound sulfamethoxazole oral tablets. The company is also involved in culture, science and technology, pharmaceutical commercial and industry, property, and investment activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.
More stocks
- Cyfrowy Polsat SA (CPS.WA)
- KCC Corporation (002380.KS)
- Konica Minolta Inc (4902.T)
- Marqeta, Inc. (MQ)
- BBMG Corp Class A (601992.SS)
- Jafron Biomedical Co Ltd (300529.SZ)
- Electricity Generating Public Company Limited (EGCO.BK)
- Denison Mines Corp (DML.TO)
- Shanghai Xinhua Media Co Ltd (600825.SS)
- Shanxi Meijin Energy Co Ltd (000723.SZ)
- Under Armour, Inc. (UA)
- Innovex International, Inc. (INVX)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.